Michael Dennis v. Monsanto Co Reference : 37-2021-00047326-CU-PO-NC Complaint date : November 5, 2021 Status : Final judgment Place of jurisdiction : United States, San Diego Plaintiffs types : Individuals Plaintiffs names : Michael (Mike) Dennis Defendants : Monsanto, Company Lawyers for Health and Environmental Justice : Love, Scott (Clark, Love & Hutson ) Peavy, Adam (Clark, Love & Hutson ) Palmer, Melanie (Kiesel Law LLP) Kiesel, Paul (Kiesel Law LLP) Case nature : Civil court Type(s), Product(s), Active substance(s) : Glyphosate, Roundup, Herbicide Requests : Recognizes that Monsanto knew of the carcinogenic risks of glyphosate, and that Monsanto concealed this information from the public to protect Roundup sales. Name of the Court : County Superior Court of San Diego, United States Jurisdiction level : No description Decision date : October 31, 2023 Decision nature : Positive Decision content : The jury found Bayer (Monsanto) liable and ordered it to pay 332 million dollars in damages. Legal basis : Court Ruling : No description Summary : On 31 October 2023, a jury for the San Diego County Court in California ordered the US company Monsanto, which was bought by Bayer in 2018, to pay $332 million to Mike Dennis, a 57-year-old former surveyor who developed non-Hodgkin's lymphoma after being exposed to Roundup. Mike Dennis used Roundup as a weedkiller in his garden for nearly 35 years. The jury found that Monsanto had not sufficiently warned Roundup users of the product's toxicity, and in particular of the carcinogenic risks. Monsanto was held liable for selling a defective product that it knew to be dangerous, and was ordered to pay $7 million in damages and $325 million in punitive damages. Bayer has already indicated that it intends to appeal the verdict, claiming that the amount awarded to Mike Dennis is excessive and that the verdict contains errors of both fact and law. Scientific references : No scientifice reference for this case. Related links : Complaint Press release, Courtroom View Network (Oct. 4, 2023) Press release, Courtroom View Network (Oct. 10, 2023) Press article, Reuters (November 1, 2023)